Stay updated on PF-07817883 Study Medicine Safety in COVID-19 Symptoms Adult Clinical Trial
Sign up to get notified when there's something new on the PF-07817883 Study Medicine Safety in COVID-19 Symptoms Adult Clinical Trial page.

Latest updates to the PF-07817883 Study Medicine Safety in COVID-19 Symptoms Adult Clinical Trial page
- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check30 days agoChange DetectedThe webpage has added a section with helpful links provided by Pfizer, which includes information on how to obtain contact details for a nearby study center.SummaryDifference0.5%
- Check37 days agoChange DetectedThe page has been updated to reflect a new version (v2.15.0) and includes a new EudraCT number for a clinical trial related to SARS-CoV-2 infection, while significant details about the study's purpose and participant criteria have been removed.SummaryDifference24%
- Check44 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check51 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check87 days agoChange DetectedThe page has removed information regarding heavy traffic affecting NLM-NCBI services and products, as well as links to contact information for Pfizer study centers.SummaryDifference1%
Stay in the know with updates to PF-07817883 Study Medicine Safety in COVID-19 Symptoms Adult Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PF-07817883 Study Medicine Safety in COVID-19 Symptoms Adult Clinical Trial page.